LifeVantage Co. (NASDAQ:LFVN) Short Interest Up 52.2% in September

LifeVantage Co. (NASDAQ:LFVN) was the recipient of a large growth in short interest in the month of September. As of September 15th, there was short interest totalling 193,700 shares, a growth of 52.2% from the August 31st total of 127,300 shares. Based on an average daily trading volume, of 79,500 shares, the short-interest ratio is presently 2.4 days. Currently, 2.0% of the shares of the company are short sold.

LifeVantage Stock Performance

NASDAQ:LFVN traded up $0.25 during mid-day trading on Friday, reaching $13.44. 52,161 shares of the company’s stock were exchanged, compared to its average volume of 54,381. LifeVantage has a one year low of $4.20 and a one year high of $13.71. The business’s fifty day simple moving average is $8.54 and its two-hundred day simple moving average is $7.32. The firm has a market capitalization of $170.70 million, a PE ratio of 47.11 and a beta of 0.82.

LifeVantage (NASDAQ:LFVN) last announced its earnings results on Wednesday, August 28th. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.07). The business had revenue of $48.93 million for the quarter. LifeVantage had a return on equity of 27.85% and a net margin of 1.47%.

LifeVantage Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 17th. Stockholders of record on Monday, September 9th were given a dividend of $0.04 per share. The ex-dividend date was Monday, September 9th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 1.19%. LifeVantage’s payout ratio is 57.14%.

Institutional Trading of LifeVantage

Several large investors have recently modified their holdings of the stock. Empowered Funds LLC boosted its position in shares of LifeVantage by 8.1% during the 1st quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock worth $461,000 after acquiring an additional 5,742 shares in the last quarter. Vanguard Group Inc. lifted its stake in LifeVantage by 2.8% during the first quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock worth $2,874,000 after purchasing an additional 12,809 shares during the last quarter. Acadian Asset Management LLC boosted its holdings in shares of LifeVantage by 2.8% in the 1st quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after purchasing an additional 6,121 shares in the last quarter. Hillsdale Investment Management Inc. bought a new position in shares of LifeVantage in the 1st quarter valued at $76,000. Finally, Hantz Financial Services Inc. acquired a new position in shares of LifeVantage during the 2nd quarter worth $91,000. 35.32% of the stock is owned by institutional investors and hedge funds.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.